Delirium is certainly not an unavoidable complication of pain control in the terminal phase of life;Delirium door pijnbestrijding in de terminale levensfase kan worden vermeden

Nederlands Tijdschrift voor Geneeskunde

Volumn 147, Issue 5, 2003, Pages 185-188

  Van Der Ligt, W ^a   Koelewijn, M ^b   Zylicz, Z ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; DEXAMETHASONE; NEUROLEPTIC AGENT; OPIATE AGONIST;

ADULT; AGED; AGING; ARTICLE; BREAST CARCINOMA; CASE REPORT; CLINICAL FEATURE; DELIRIUM; DISEASE ASSOCIATION; DISEASE COURSE; DYING; FEMALE; HUMAN; INTRACTABLE PAIN; LUNG SMALL CELL CANCER; MALE; NEUROPATHIC PAIN; OSTEOSARCOMA; PAIN; PAIN ASSESSMENT; QUALITY OF LIFE; TERMINALLY ILL PATIENT; TREATMENT PLANNING;

ADULT; AGED; ANALGESIA; ANALGESICS; ANALGESICS, OPIOID; DELIRIUM; FEMALE; HUMANS; MALE; PAIN, INTRACTABLE; PALLIATIVE CARE;

EID: 0037319654     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Lawlor PG, Gagnon B, Mancini IL, Pereira JL, Hanson J, Suarez-Alamazor M, et al. Delirium as a predictor of survival in older patients with advanced cancer. Arch Intern Med 2000;160:2866-8.
2. Meagher DJ. Delirium: optimising management. BMJ 2001:322:144-9.
3. Morita T, Tei Y, Tsunoda J, Inoue S, Chihara S. Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. J Pain Symptom Manage 2001;22:997-1006.
4. Waale WH, Bruijns E, Dautzenberg PJ. Een delier bij blaasretentie: verwarrend voor patiënt en dokter. Tijdschr Gerontol Geriatr 2001; 32:100-3.
5. Camus V, Gonthier R, Dubos G, Schwed P, Simeone I. Etiologic and outcome profiles in hypoactive and hyperactive subtypes of delirium. J Geriatr Psychiatry Neurol 2000;13:38-42.
6. De Stoutz ND, Bruera E, Suarez-Almazor M. Opioid rotation for toxicity reduction in terminal cancer patient. J Pain Symptom Manage 1995;10:378-84.
7. Maddocks I, Somogyi A, Abbott F, Hayball P, Parker D. Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone. J Pain Symptom Manage 1996:12:182-9.
8. Weber WE. Farmacotherapie van neuropathische pijn door letsel van afferente zenuwvezels. Ned Tijdschr Geneeskd 2001;145:813-7.
9. Vollmer KO, von Hodenberg A, Kolle EU. Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Arzneimittelforschung 1986;36:830-9.
10. Akechi T, Uchitomi Y, Okamura H, Fukue M, Kagaya A, Nishida A, et al. Usage of haloperidol for delirium in cancer patients. Support Care Cancer 1996;4:390-2.
11. Breitbart W, Marotta R, Platt MM, Weisman F, Derevenco M, Grau C, et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996;153:231-7.
12. Battaglia J, Moss S, Rush J, Kang J, Mendoza R, Leedom L, et al. Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study. Am J Emerg Med 1997;15:335-40.
13. Skinner J, Skinner A. Levomepromazine for nausea and vomiting in advanced cancer. Hosp Med 1999;60:568-70.